IMPRINT

© Copyright 2021. TraceBOT - all rights reserved.

TraceBOT is receiving funding from the European Union‘s H2020-EU.2.1.1. INDUSTRIAL LEADERSHIP programme (grant agreement No 101017089).
Duration: January 2021 till March 2025.

The TraceBOT project consists of a consortium of six partners: Astech Projects Limited (England), Commissariat à l‘Energie Atomique et aux Energies Alternatives (France), Fundación Tecnalia Research & Innovation (Spain), Invite GmbH (Germany), Technische Universität Wien (Austria) and Universität Bremen (Germany) and guided by representatives of the pharmaceutical industry.

The TraceBOT project’s coordination, communication and dissemination is carried out by the health network BioLAGO.

For any queries concerning the TraceBOT project, please contact BioLAGO at:

TraceBOT
c/o BioLAGO e.V. – The Health Network
Byk-Gulden-Str. 2
D-78467 Constance (Germany)

Tel. +49 (0)7531 – 921 525 0
E-Mail: info@tracebot.eu

 

Commercial Register of BioLAGO e.V.:

Register Court: District Court Freiburg, VR 380872

VAT ID: DE 258 862 583

DISCLAIMER:

The content of this website is the sole responsibility of the publishers (The TraceBOT Consortium with its members as described above) and it does not necessarily represent the views expressed by the European Commission or its services.

While the information contained in this website is believed to be accurate, the author(s) or any other participant in the TraceBOT consortium make no warranty of any kind with regard to the content including, but not limited to the implied warranties of merchantability and fitness for a particular purpose.

Neither the TraceBOT Consortium nor any of its members, their officers, employees or agents shall be responsible or liable in negligence or otherwise howsoever in respect of any inaccuracy or omission herein.

Without derogating from the generality of the foregoing neither the TraceBOT consortium nor any of its members, their officers, employees or agents shall be liable for any direct or indirect or consequential loss or damage caused by or arising from any information advice or inaccuracy or omission herein.